Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bioventus (BVS) EPS (Basic) (2021 - 2026)

Bioventus filings provide 5 years of EPS (Basic) readings, the most recent being $0.22 for Q4 2025.

  • On a quarterly basis, EPS (Basic) changed N/A to $0.22 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.34, a 160.71% increase, with the full-year FY2025 number at $0.34, up 160.71% from a year prior.
  • EPS (Basic) hit $0.22 in Q4 2025 for Bioventus, up from $0.05 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.22 in Q4 2025 to a low of -$1.76 in Q4 2022.
  • Median EPS (Basic) over the past 5 years was -$0.08 (2024), compared with a mean of -$0.32.
  • Biggest five-year swings in EPS (Basic): plummeted 201797.82% in 2022 and later soared 162.5% in 2025.
  • Bioventus' EPS (Basic) stood at -$0.0 in 2021, then plummeted by 201797.82% to -$1.11 in 2022, then increased by 6.31% to -$1.04 in 2023, then surged by 92.31% to -$0.08 in 2024, then soared by 375.0% to $0.22 in 2025.
  • The last three reported values for EPS (Basic) were $0.22 (Q4 2025), $0.05 (Q3 2025), and $0.11 (Q2 2025) per Business Quant data.